NCT02684253View on ClinicalTrials.gov

Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 11, 2016

Primary Completion Date

January 22, 2021

Study Completion Date

January 22, 2021

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Interventions

DRUG

Nivolumab

RADIATION

Stereotactic Body Radiation Therapy (SBRT)

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11725

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack

Unknown

Memoral Sloan Kettering Cancer Center, Basking Ridge

Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre

07748

Memorial Sloan Kettering Monmouth, Middletown

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02684253 - Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) | Biotech Hunter | Biotech Hunter